Literature DB >> 20012628

Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.

Waqar Haque1, Huseyin Kadikoy, Omar Pacha, Joseph Maliakkal, Vu Hoang, Abdul Abdellatif.   

Abstract

Osteonecrosis is commonly present in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Treatment of this condition remains extremely controversial. We present a treatment strategy of avascular necrosis of the knee in a patient with catastrophic antiphospholipid syndrome with a history of SLE and APS. Aggressive treatment with 12 rounds of plasmapheresis, intravenous immunoglobulin, rituximab, and cyclophosphamide led to the patient's recovery with no recurrence of symptoms during 16 months of follow up. In this report, we further discuss the pathogenesis of osteonecrosis and current understanding of the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012628     DOI: 10.1007/s00296-009-1269-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  39 in total

1.  Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.

Authors:  Michael A Mont; Slif D Ulrich; Thorsten M Seyler
Journal:  J Rheumatol       Date:  2007-03       Impact factor: 4.666

2.  Primary antiphospholipid syndrome and osteonecrosis.

Authors:  P Vela; E Batlle; E Salas; P Marco
Journal:  Clin Exp Rheumatol       Date:  1991 Sep-Oct       Impact factor: 4.473

3.  Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.

Authors:  E Marciniak; E H Romond
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

4.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

5.  Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.

Authors:  K Nagasawa; Y Ishii; T Mayumi; Y Tada; A Ueda; Y Yamauchi; T Kusaba; Y Niho
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

6.  Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.

Authors:  S Agarwala; D Jain; V R Joshi; A Sule
Journal:  Rheumatology (Oxford)       Date:  2004-11-30       Impact factor: 7.580

7.  Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis.

Authors:  Shigeru Otsubo; Kosaku Nitta; Wako Yumura; Hiroshi Nihei; Noriko Mori
Journal:  Intern Med       Date:  2002-09       Impact factor: 1.271

8.  Hypofibrinolysis: a common, major cause of osteonecrosis.

Authors:  C J Glueck; R Freiberg; H I Glueck; C Henderson; M Welch; T Tracy; D Stroop; T Hamer; F Sosa; M Levy
Journal:  Am J Hematol       Date:  1994-02       Impact factor: 10.047

Review 9.  Orthopedic involvement in antiphospholipid syndrome.

Authors:  Alexander Gorshtein; Yair Levy
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

10.  Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.

Authors:  M Ieko; K Ichikawa; D A Triplett; E Matsuura; T Atsumi; K Sawada; T Koike
Journal:  Arthritis Rheum       Date:  1999-01
View more
  6 in total

1.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

2.  Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.

Authors:  Lidan Zhao; Xiuhua Wu; Honghua Wu; Jinmei Su; Wen Zhang; Yan Zhao; Xuan Zhang; Wenjie Zheng
Journal:  Rheumatol Int       Date:  2016-05-26       Impact factor: 2.631

3.  Treatment options for secondary osteonecrosis of the knee.

Authors:  Hassan Zmerly; Manuela Moscato; Ibrahim Akkawi; Riccardo Galletti; Valentina Di Gregori
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

4.  Autologous Osteochondral Transplantation for Young Patients with Postcollapse Osteonecrosis of the Knee: A Retrospective Cohort Study with an Average 7-Year Follow-Up.

Authors:  Jinhui Ma; Yansong Ren; Bailiang Wang; Debo Yue; Wei Sun; Weiguo Wang
Journal:  Cartilage       Date:  2021-06-17       Impact factor: 3.117

5.  Fresh Osteochondral Allograft Transplantation for Spontaneous Osteonecrosis of the Knee: A Case Series.

Authors:  Luís E P Tírico; Samuel A Early; Julie C McCauley; William D Bugbee
Journal:  Orthop J Sports Med       Date:  2017-10-03

Review 6.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.